The excellent results of minimally invasive mitral valve repair must be considered whenever already available or any new transcatheter techniques are offered.
Further evaluations with multiple dose in vitro and in vivo investigations are needed before specific voriconazole dosing recommendations can be made for clinical application with extracorporeal membrane oxygenation.
